CaMKII inhibitors (University of Illinois/University of Illinois at URBANA-CHAMPAIGN)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCaMKII inhibitors (University of Illinois/University of Illinois at URBANA-CHAMPAIGN)
Drug Alias Namecalmodulin-dependent protein kinase II inhibitors (University of Illinois/University of Illinois at URBANA-CHAMPAIGN)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/Calmodulin dependent protein kinase II inhibitors
TargetsCalcium/Calmodulin dependent protein kinase II
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of IllinoisUniversity Of Illinois At Urbana–Champaign
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A